Refractory solid tumors Clinical Trials

Delta Trials tracks 33 clinical trials for Refractory solid tumors in its publicly accessible dataset. Among the listed trials, 6 open for participant enrollment and 20 trials have reached completion. This research is carried out at 66 clinical sites around the world. An additional 7 trials have active registrations outside the recruiting and completed categories. Since 2020, 4 trials have been terminated before reaching their primary endpoint. This dataset is refreshed continuously as trial statuses are updated on ClinicalTrials.gov, capturing longitudinal changes in the research landscape.